Cargando…
Crystal structure of nafamostat dimesylate
Nafamostat dimesylate {systematic name: [amino({6-[(4-{[amino(iminiumyl)methyl]amino}phenyl)carbonyloxy]naphthalen-2-yl})methylidene]azanium bis(methanesulfonate)}, C(19)H(19)N(5)O(2) (2+)·2CH(3)O(3)S(−), is a broad-spectrum serine protease inhibitor and has been applied clinically as an anticoagul...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491525/ https://www.ncbi.nlm.nih.gov/pubmed/34667626 http://dx.doi.org/10.1107/S2056989021009245 |
_version_ | 1784578749462740992 |
---|---|
author | Fujii, Isao |
author_facet | Fujii, Isao |
author_sort | Fujii, Isao |
collection | PubMed |
description | Nafamostat dimesylate {systematic name: [amino({6-[(4-{[amino(iminiumyl)methyl]amino}phenyl)carbonyloxy]naphthalen-2-yl})methylidene]azanium bis(methanesulfonate)}, C(19)H(19)N(5)O(2) (2+)·2CH(3)O(3)S(−), is a broad-spectrum serine protease inhibitor and has been applied clinically as an anticoagulant agent during hemodialysis and for treatment of severe acute pancreatitis (SAP). Since nafamostat contains flexible moieties, it is necessary to determine the conformation to understand the structure–activity relationships. The divalent cation has a screw-like motif. The guanidinium group is approximately perpendicular to the naphthyl ring system, subtending a dihedral angle of 84.30 (14)°. In the crystal, the nafamostat molecules form columnar structures surrounded by a hydrophilic region. |
format | Online Article Text |
id | pubmed-8491525 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | International Union of Crystallography |
record_format | MEDLINE/PubMed |
spelling | pubmed-84915252021-10-18 Crystal structure of nafamostat dimesylate Fujii, Isao Acta Crystallogr E Crystallogr Commun Research Communications Nafamostat dimesylate {systematic name: [amino({6-[(4-{[amino(iminiumyl)methyl]amino}phenyl)carbonyloxy]naphthalen-2-yl})methylidene]azanium bis(methanesulfonate)}, C(19)H(19)N(5)O(2) (2+)·2CH(3)O(3)S(−), is a broad-spectrum serine protease inhibitor and has been applied clinically as an anticoagulant agent during hemodialysis and for treatment of severe acute pancreatitis (SAP). Since nafamostat contains flexible moieties, it is necessary to determine the conformation to understand the structure–activity relationships. The divalent cation has a screw-like motif. The guanidinium group is approximately perpendicular to the naphthyl ring system, subtending a dihedral angle of 84.30 (14)°. In the crystal, the nafamostat molecules form columnar structures surrounded by a hydrophilic region. International Union of Crystallography 2021-09-10 /pmc/articles/PMC8491525/ /pubmed/34667626 http://dx.doi.org/10.1107/S2056989021009245 Text en © Isao Fujii 2021 https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited. |
spellingShingle | Research Communications Fujii, Isao Crystal structure of nafamostat dimesylate |
title | Crystal structure of nafamostat dimesylate |
title_full | Crystal structure of nafamostat dimesylate |
title_fullStr | Crystal structure of nafamostat dimesylate |
title_full_unstemmed | Crystal structure of nafamostat dimesylate |
title_short | Crystal structure of nafamostat dimesylate |
title_sort | crystal structure of nafamostat dimesylate |
topic | Research Communications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491525/ https://www.ncbi.nlm.nih.gov/pubmed/34667626 http://dx.doi.org/10.1107/S2056989021009245 |
work_keys_str_mv | AT fujiiisao crystalstructureofnafamostatdimesylate |